Metronidazol B. Braun

Metronidazole, the active ingredient in Metronidazol B. Braun, is a nitroimidazole antibiotic presented as an intravenous solution for intravenous use. It treats anaerobic bacterial infections and selected protozoal infections in hospitalized patients.

GNH USA supplies Metronidazol B. Braun as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Metronidazol B. Braun is a nitroimidazole that targets anaerobic bacteria and certain protozoa. It is employed in several clinical scenarios: - Anaerobic bacterial infections: eradicates susceptible anaerobes and resolves infection. - Bacterial vaginosis: restores normal vaginal flora by eliminating pathogenic anaerobes. - Trichomoniasis: eliminates Trichomonas vaginalis, relieving symptoms. - Intra‑abdominal infections: provides coverage for mixed aerobic‑anaerobic infections after surgery. - Surgical prophylaxis for anaerobic coverage: reduces postoperative infection risk when anaerobes are anticipated.

Metronidazol B. Braun may cause a range of adverse reactions. Most are mild and reversible, but serious events can occur.

Common Side Effects: - Nausea: mild to moderate upset stomach. - Metallic taste: transient metallic sensation in the mouth. - Headache: mild to moderate headache. - Diarrhea: loose stools during therapy.

Serious or Rare Side Effects: - Seizures: rare neurologic events, especially with high doses. - Peripheral neuropathy: tingling or numbness in extremities. - Severe allergic reactions: anaphylaxis, rash, or swelling requiring immediate medical attention.

Before initiating therapy, clinicians should consider several safety measures. - Assess renal function: adjust therapy if creatinine clearance is reduced. - Monitor liver enzymes: watch for hepatic toxicity during prolonged use. - Avoid alcohol: concurrent intake can cause a disulfiram‑like reaction. - Use with caution in pregnancy: category B3 indicates potential risk; weigh benefits against risks. - Adjust dose in hepatic impairment: reduced clearance may require dose modification. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze.

Metronidazol B. Braun can alter the activity of other medicines. Awareness of key interactions helps prevent adverse outcomes.

Major Interactions (Avoid): - Alcohol: may trigger severe flushing, nausea, and tachycardia. - Warfarin: potentiates anticoagulant effect, increasing bleeding risk. - Lithium: can raise lithium serum levels, risking toxicity.

Moderate Interactions (Monitor Closely): - Cimetidine: may increase metronidazole plasma concentrations. - Oral contraceptives: may reduce hormonal efficacy, requiring alternative contraception.